Vilin Bio Med Ltd

Vilin Bio Med Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vilin Bio Med Ltd

₹ 44.2 -4.84%
14 Jul - close price
vilinbiomed.co.in NSE - SME: VILINBIO
About

Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products[1]

Key Points

Business Overview:[1][2]
VBML is an ISO-9001-2008 & GMP certified manufacturer of Pharmaceutical formulations' viz. Oral Liquid (Syrups/Suspensions/Dry Powders (βeta & Non βeta-Lactam), Tablets & Capsules (βeta & Non βeta-Lactam), External Preparations, etc. It sells its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders. Company does not sell products under any brand name

Website NSE - SM
  • Market Cap ₹ 67.5 Cr.
  • Current Price ₹ 44.2
  • High / Low ₹ 54.4 / 19.0
  • Stock P/E 35.0
  • Book Value ₹ 18.6
  • Dividend Yield 0.00 %
  • ROCE 10.8 %
  • ROE 7.51 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -4.08%
  • Company has a low return on equity of 3.53% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
4.95 4.10 8.21 7.65 8.16 4.49 10.32 9.66 32.60
4.56 2.99 6.74 6.26 8.73 4.07 9.95 9.32 29.74
Operating Profit 0.39 1.11 1.47 1.39 -0.57 0.42 0.37 0.34 2.86
OPM % 7.88% 27.07% 17.90% 18.17% -6.99% 9.35% 3.59% 3.52% 8.77%
0.00 0.00 0.02 0.11 0.22 0.22 0.25 0.00 0.00
Interest 0.25 0.32 0.33 0.38 0.41 0.41 0.44 0.07 0.00
Depreciation 0.11 0.08 0.08 0.08 0.05 0.07 0.03 0.07 0.21
Profit before tax 0.03 0.71 1.08 1.04 -0.81 0.16 0.15 0.20 2.65
Tax % 33.33% 21.13% 35.19% 25.96% -25.93% 18.75% 33.33% 25.00% 32.83%
0.02 0.55 0.69 0.77 -0.61 0.12 0.10 0.15 1.78
EPS in Rs 0.06 1.67 0.69 0.55 -0.44 0.09 0.07 0.11 1.17
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
16.62 11.54 11.21 12.31 15.80 14.81 42.26
15.71 10.68 10.44 9.73 14.97 14.02 39.06
Operating Profit 0.91 0.86 0.77 2.58 0.83 0.79 3.20
OPM % 5.48% 7.45% 6.87% 20.96% 5.25% 5.33% 7.57%
0.01 0.00 0.00 0.02 0.32 0.47 0.00
Interest 0.41 0.44 0.51 0.65 0.79 0.85 0.07
Depreciation 0.31 0.26 0.22 0.17 0.13 0.10 0.28
Profit before tax 0.20 0.16 0.04 1.78 0.23 0.31 2.85
Tax % 20.00% 25.00% 25.00% 30.34% 26.09% 25.81% 31.93%
0.16 0.12 0.03 1.25 0.16 0.22 1.93
EPS in Rs 0.48 0.36 0.09 1.26 0.11 0.16 1.27
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 51%
TTM: 185%
Compounded Profit Growth
10 Years: %
5 Years: 74%
3 Years: 16%
TTM: 777%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 28%
1 Year: 72%
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 4%
Last Year: 8%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.30 3.30 3.30 9.95 13.95 13.95 15.25
Reserves 3.94 4.06 4.10 0.73 8.89 9.11 13.12
4.53 5.52 5.30 4.93 6.83 2.57 0.21
2.24 1.01 0.86 2.07 2.73 2.10 6.36
Total Liabilities 14.01 13.89 13.56 17.68 32.40 27.73 34.94
2.13 1.87 1.65 1.51 1.38 1.28 2.87
CWIP 0.00 0.00 0.00 0.00 0.00 1.57 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
11.88 12.02 11.91 16.17 31.02 24.88 32.07
Total Assets 14.01 13.89 13.56 17.68 32.40 27.73 34.94

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1.46 -1.00 0.21 -1.66 -7.42 0.22 0.70
-0.02 0.00 0.00 -0.03 0.32 -1.11 -0.30
1.51 0.98 -0.22 1.68 8.87 -5.10 1.01
Net Cash Flow 0.03 -0.02 -0.01 0.00 1.77 -5.99 1.41
Free Cash Flow -1.48 -1.00 0.21 -1.69 -7.42 -1.35 0.40
CFO/OP -156% -112% 29% -43% -888% 37% 49%

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 159.66 241.96 253.64 166.04 131.22 155.51 137.85
Inventory Days 56.13 83.17 93.82 44.74 125.41 119.50 70.03
Days Payable 49.48 33.11 26.34 60.49 54.71 37.67 32.49
Cash Conversion Cycle 166.31 292.03 321.13 150.28 201.91 237.35 175.38
Working Capital Days 110.91 204.32 211.64 45.07 76.23 195.44 168.16
ROCE % 4.87% 4.30% 17.17% 4.51% 4.20% 10.77%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025
Capital Work in Progress (Capacity Expansion)
Rs. Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Cost of Materials Consumed (Raw Material Volume)
Rs. Lakhs
Employee Benefits Expense (Workforce)
Rs. Lakhs
Finished Goods Inventory (Production Output Held)
Rs. Lakhs
Electricity Consumption (Manufacturing Activity)
units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026May 2026
90.45% 64.52% 64.52% 64.09% 63.89% 63.89% 63.89% 63.65% 59.57% 56.65%
9.55% 35.48% 35.48% 35.91% 36.11% 36.11% 36.11% 36.35% 40.43% 43.35%
No. of Shareholders 21659585581551492476462397400

Documents

Announcements

Annual reports